WallStSmart

Henry Schein Inc (HSIC)vsSynergy CHC Corp. Common Stock (SNYR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Henry Schein Inc generates 38019% more annual revenue ($13.18B vs $34.59M). SNYR leads profitability with a 7.5% profit margin vs 3.0%. SNYR trades at a lower P/E of 4.2x. HSIC earns a higher WallStSmart Score of 56/100 (C).

HSIC

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.5Value: 8.7Quality: 7.0
Piotroski: 5/9Altman Z: 2.71

SNYR

Hold

45

out of 100

Grade: D

Growth: 4.3Profit: 6.0Value: 7.0Quality: 7.0
Piotroski: 4/9Altman Z: -0.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HSICUndervalued (+12.5%)

Margin of Safety

+12.5%

Fair Value

$93.39

Current Price

$74.25

$19.14 discount

UndervaluedFair: $93.39Overvalued
SNYRUndervalued (+13.2%)

Margin of Safety

+13.2%

Fair Value

$1.90

Current Price

$1.17

$0.73 discount

UndervaluedFair: $1.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HSIC1 strengths · Avg: 8.0/10
Price/BookValuation
2.6x8/10

Reasonable price relative to book value

SNYR2 strengths · Avg: 10.0/10
P/E RatioValuation
4.2x10/10

Attractively priced relative to earnings

Debt/EquityHealth
-3.0410/10

Conservative balance sheet, low leverage

Areas to Watch

HSIC3 concerns · Avg: 3.3/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

Profit MarginProfitability
3.0%3/10

3.0% margin — thin

Debt/EquityHealth
1.023/10

Elevated debt levels

SNYR4 concerns · Avg: 2.5/10
Market CapQuality
$13.16M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Return on EquityProfitability
-3.6%2/10

ROE of -3.6% — below average capital efficiency

EPS GrowthGrowth
-90.6%2/10

Earnings declined 90.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : HSIC

The strongest argument for HSIC centers on Price/Book.

Bull Case : SNYR

The strongest argument for SNYR centers on P/E Ratio, Debt/Equity. Revenue growth of 12.4% demonstrates continued momentum.

Bear Case : HSIC

The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.

Bear Case : SNYR

The primary concerns for SNYR are Market Cap, Profit Margin, Return on Equity.

Key Dynamics to Monitor

SNYR carries more volatility with a beta of 1.27 — expect wider price swings.

SNYR is growing revenue faster at 12.4% — sustainability is the question.

HSIC generates stronger free cash flow (338M), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HSIC scores higher overall (56/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Henry Schein Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.

Visit Website →

Synergy CHC Corp. Common Stock

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Synergy CHC Corp. The company is headquartered in Westbrook, Maine.

Want to dig deeper into these stocks?